Related by context. All words. (Click for frequent words.) 77 lymph node metastases 75 lymphovascular invasion 74 mRNA expression 74 FDG uptake 74 lymph node involvement 74 distant metastasis 73 distant metastases 73 nodal metastasis 72 PCa 72 immunoreactivity 72 pT3 72 urothelial carcinoma 72 nodal metastases 72 gastric carcinoma 72 prostate carcinoma 72 node metastases 71 histologic 71 extracapsular extension 71 esophageal carcinoma 71 pT2 71 thyroglobulin 71 preoperative PSA 71 biochemical recurrence 71 thyroid carcinoma 71 micrometastasis 71 TIMP 71 prostate cancer CaP 71 mucinous 71 seminal vesicle invasion 70 HER2 expression 70 cTnI 70 lactate dehydrogenase 70 peritumoral 70 histological subtype 70 breast carcinoma 70 liver metastasis 70 clinicopathological features 70 lymphocytosis 70 lymphadenectomy 70 ultrasonographic 70 lung metastasis 70 SUVmax 70 colorectal carcinoma 70 ERBB2 70 tumoral 70 Ki# 69 gadolinium enhanced 69 TIMP 1 69 morphologic 69 prognostic factor 69 echogenicity 69 lobular carcinoma 69 immunostaining 69 prognostic significance 69 hyperintensity 69 chemosensitivity 69 ovarian carcinoma 69 locoregional recurrence 69 PSADT 69 immunohistochemical 69 intact parathyroid hormone 69 GSTP1 69 pancreatic adenocarcinoma 69 multivariable analysis 69 splenic 69 gastric adenocarcinoma 69 hypointense 69 cytokeratin 69 metastases 69 pulmonary metastases 69 metachronous 69 perineural invasion 69 alkaline phosphatase ALP 69 T1a 69 epithelial tumors 69 pCR 68 T2 weighted images 68 advanced adenomas 68 microvessel density 68 locoregional 68 univariate analysis 68 cellularity 68 transgene expression 68 RRM1 68 intima media thickness 68 MLH1 68 F FDG PET 68 carcinoembryonic antigen 68 ERalpha 68 rs# [004] 68 breast carcinomas 68 isoenzyme 68 P cadherin 68 neoplasm 68 paragangliomas 68 CIN2 + 68 hypoperfusion 68 hyperplastic 68 tumor necrosis 68 metaplasia 68 TNFalpha 68 immunoreactive 68 situ LCIS 68 histopathologic 68 parenchymal 68 histologic subtype 68 estrogen receptor ER 68 invasive ductal 68 rs# [002] 67 immunohistochemical staining 67 lactate dehydrogenase LDH 67 multivariate Cox 67 hamartomas 67 endometrial carcinoma 67 tumorigenicity 67 contralateral breast 67 axillary lymph nodes 67 tumor recurrence 67 atypical hyperplasia 67 malignant nodules 67 ipsilateral 67 adrenocortical 67 urothelial 67 prognostic indicator 67 specific antigen PSA 67 microsatellite instability 67 poorer prognosis 67 scintigraphic 67 SLNB 67 papillary thyroid carcinoma 67 TGFß 67 precursor lesions 67 gastric cardia 67 invasive carcinomas 67 ductal 67 histopathological 67 gene polymorphisms 67 epididymal 67 lymphocytic 67 neoplastic 67 luminal 67 Lymph node 67 Immunohistochemical staining 67 colorectal adenoma 67 intestinal metaplasia 67 ERCC1 67 Immunohistochemical analysis 67 pathologic 67 HRCT 67 VEGF expression 67 homozygotes 67 proto oncogene 67 advanced adenoma 67 intratumoral 67 detrusor 67 histologically 67 clinicopathological 67 colorectal adenocarcinoma 66 carcinomas 66 eosinophil count 66 mediastinal 66 sarcomatoid 66 platelet reactivity 66 caveolin 1 66 papillary 66 operable breast cancer 66 hilar 66 tracer uptake 66 EUS FNA 66 ischemic lesions 66 HGPIN 66 intraobserver 66 Clusterin 66 neoplasia 66 c MYC 66 ^ sup #m 66 adenoma 66 PTPN# 66 autoregulation 66 rs# [001] 66 Doppler sonography 66 cells transfected 66 HepG2 cells 66 colocalization 66 troponin T 66 submucosal 66 lobular carcinomas 66 metastatic lesions 66 metastatic lesion 66 Figure 2C 66 serum prostate 66 heterozygotes 66 LV ejection fraction 66 proximal colon 66 invasive carcinoma 66 ABCB1 66 grade squamous intraepithelial 66 K ras mutations 66 epithelia 66 immunohistochemical analysis 66 thyroid peroxidase 66 endoscopic ultrasonography 66 intrahepatic 66 adrenalectomy 66 adenocarcinomas 66 CK MB 66 MAPK pathway 66 choroidal 66 MSH2 66 cell adhesion molecule 66 cytologic 66 inducible nitric oxide synthase 66 Supplementary Fig 66 RASSF1A 66 progesterone receptor PR 66 glomerular 66 biochemical relapse 66 transabdominal 66 prostate cancer PCa 66 histopathologic examination 66 serum PSA 66 steroidogenesis 65 nonmetastatic 65 locoregional disease 65 B7 H3 65 axillary lymph node 65 karyotype 65 advanced neoplasia 65 MALT lymphoma 65 T1c 65 malignant lesions 65 lymphoid cells 65 underwent resection 65 KRAS mutations 65 neoplastic cells 65 neoadjuvant chemotherapy 65 leukocyte count 65 TOP2A 65 extranodal 65 infarct size 65 CIN2 65 CD# expression [001] 65 alanine aminotransferase 65 BRCA2 mutation carriers 65 neoplasias 65 cervical lymph nodes 65 tumor histology 65 TUNEL 65 PC3 cells 65 μg ml 65 PSA nadir 65 adenomatous 65 hepatocellular carcinomas 65 kidney allograft 65 CagA 65 CIN3 65 GISTs 65 microglial 65 LV dysfunction 65 neoplastic lesions 65 serum albumin 65 SCr 65 SNP rs# [002] 65 histologic findings 65 P = .# 65 lymphoid 65 myocardial necrosis 65 micrometastases 65 iNOS 65 HNSCC 65 adenoma recurrence 65 thyrotropin 65 autoantibody 65 lymphocyte count 65 osteoid 65 pituitary adenomas 65 pleomorphic 65 sonographic findings 65 metastasis 65 hypermethylated 65 CD#b 65 Fig. 3b 65 adjuvant radiotherapy 65 lung carcinomas 65 hydronephrosis 65 CD# expression [002] 65 ductal carcinomas 65 hyperintensities 65 myometrial 65 colon carcinoma 65 atypia 65 EGFR mutant 65 alanine aminotransferase ALT 65 periventricular 65 axillary node 65 rCBF 65 serum concentrations 65 Leydig cell 65 isoform 65 schwannomas 65 BRAF V#E mutation 65 leiomyoma 65 epithelial ovarian cancer 65 methylenetetrahydrofolate reductase 65 adnexal mass 65 radiotherapy RT 65 parathyroid 65 endometrial thickness 65 F FDG uptake 65 BRAF V#E 65 lymphangiogenesis 65 CEACAM1 65 hormone receptor status 64 Fig. 1D 64 para aortic 64 leukocytosis 64 renal tumors 64 surgically resected 64 resected 64 EpCAM expression 64 etiologic 64 HER2 neu 64 FDG-PET/CT 64 steroidogenic 64 normal karyotype 64 ER alpha 64 cyclin E 64 ADPKD 64 multivariate analyzes 64 prognostic marker 64 carcinoids 64 metastatic lymph nodes 64 IL 1ß 64 EBRT 64 carotid IMT 64 tPSA 64 pelvic lymphadenectomy 64 HBeAg 64 NMIBC 64 FDG PET 64 umbilical vein 64 localized renal 64 resectable 64 Histologic 64 TGF β 64 PSA kinetics 64 tHcy 64 parasitaemia 64 leiomyomas 64 distal colon 64 HER2 overexpression 64 interobserver 64 radiographic findings 64 leukemic cell 64 atheroma volume 64 Rap1 64 hypoechoic 64 obstructive coronary artery 64 renal cell carcinomas 64 MMP# 64 stromal 64 radical prostatectomy RP 64 trophoblast cells 64 hamartoma 64 mammographic density 64 response pCR 64 troponins 64 ASCUS 64 hormone receptor negative 64 SOX9 64 μmol L 64 % CI #.#-#.# [007] 64 extramedullary 64 TRUS 64 amyloid deposition 64 COL#A# 64 AST ALT 64 sonographic 64 axillary dissection 64 isoprostane 64 protein tyrosine phosphatase 64 grade cervical intraepithelial 64 neointimal 64 c Src 64 mesotheliomas 64 creatine kinase MB 64 xenograft tumors 64 lymph node dissection 64 miRNA expression 64 serum ALT 64 MTT assay 64 hypermethylation 64 sentinel lymph node biopsy 64 immunoblotting 64 atherosclerotic lesion 64 pheochromocytomas 64 completely resected 64 independent prognostic marker 64 fig. S4 64 TNF α 64 hemoglobin Hb 64 Papillary 64 renal carcinoma 64 esophageal squamous cell carcinoma 64 intraventricular 64 intravesical therapy 64 HER2 amplification 64 SPINK1 64 neoadjuvant 64 cystectomy 64 clonogenic 64 HCT# 64 cystatin C 64 papillary renal cell carcinoma 64 ectopic expression 64 tryptase 64 axillary nodes 64 p# biomarker 64 ERK1 2 64 rs# [003] 64 seropositivity 64 oligomerization 64 induced apoptosis 64 neoplasms 64 NGAL 64 HbF 64 parenchyma 64 Leydig cells 64 echogenic 64 malignant neoplasm 64 colorectal neoplasms 64 pDC 64 androgen dependent 64 contralateral 64 bone scintigraphy 64 univariate 64 chromosomal mutations 64 cervical carcinoma 64 renal cysts 64 metastatic malignant 64 supratentorial 63 prostate adenocarcinoma 63 cAMP signaling 63 thyroid nodules 63 malignant prostate 63 postoperative mortality 63 penetrance 63 TOP2A gene 63 orthotopic 63 MMP9 63 p# Shc 63 appendiceal 63 total thyroidectomy 63 explants 63 LNCaP cells 63 neoadjuvant therapy 63 osteochondroma 63 hypothalamic pituitary 63 bladder carcinoma 63 Univariate analysis 63 S#A# [002] 63 sonographic evaluation 63 seminomas 63 alveolar epithelial cells 63 myeloperoxidase 63 downregulated 63 monocyte chemoattractant protein 63 HOMA IR 63 renal pelvis 63 ductal lobular 63 fig. S1 63 pg ml 63 FGFR3 63 hematological relapse 63 ß catenin 63 aggrecan 63 β catenin 63 endothelial cell 63 liver histology 63 serous ovarian cancer 63 myometrium 63 hypomethylation 63 androgen deprivation 63 p#HER# 63 univariate analyzes 63 seminal vesicle 63 interleukin IL -6 63 clinicopathologic 63 prostatic 63 motoneurons 63 tissue oxygenation 63 prognostic factors 63 interobserver reliability 63 logistic regression analysis 63 coexpression 63 axillary 63 tyrosine phosphorylation 63 tumor infiltrating lymphocytes 63 EphB4 63 erythrocyte sedimentation rate 63 cardiac troponin T 63 μg liter 63 haematopoietic 63 IL#B 63 nodular 63 neutrophil count 63 imatinib therapy 63 HLA DR 63 pericardial effusion 63 umbilical artery 63 BRAF mutations 63 #p# [003] 63 progesterone receptor negative 63 hypervascular 63 FasL 63 PECAM 1 63 perioperative morbidity 63 colonic polyps 63 promoter methylation 63 HIF 1alpha 63 mediastinum 63 transesophageal echocardiography 63 HOXB# 63 thymoma 63 WT1 63 Endometrial 63 confidence intervals CIs 63 endothelial activation 63 fluorescence intensity 63 inhibin B 63 AGTR1 63 hepatocellular 63 overexpression 63 proteoglycan 63 sentinel node 63 papillary RCC 63 fractional anisotropy 63 PTHrP 63 H#K#me# 63 cardiac dysfunction 63 GFAP 63 femoral neck fracture 63 p# mutation 63 lymphadenopathy 63 CR nPR 63 angiographically 63 LVNC 63 postoperative morbidity 63 pheochromocytoma 63 coronary stenosis 63 caveolin 63 airway hyperresponsiveness 63 E#F# 63 erythrocyte 63 Elevated serum 63 TGF ß1 63 subcellular localization 63 synovial 63 nitrotyrosine 63 serum PTH 63 cathepsin B 63 vascularization 63 Figure 1A 63 mesenteric 63 endometrial 63 pulmonary nodules 63 oncogenic transformation 63 Circulating tumor cells 63 inhibin 63 SNP rs# [001] 63 thickness IMT 63 constitutively active 63 sensitivity specificity 63 interleukin IL -# 63 gene polymorphism 63 breast cancer metastasis 63 SSc 63 CD# + [001] 63 NKG2D 63 factor PlGF 63 prognostic biomarker 63 Angiotensin converting enzyme 63 Mutational 63 Lp PLA 2 63 HER2/neu 63 autophagic 63 polypoid 63 vimentin 63 highest tertile 63 carcinoid tumor 63 histopathologic diagnosis 63 mediastinal lymph nodes 63 Kaplan Meier analysis 63 ErbB2 63 prognostic variables 63 premalignant 63 postoperative chemotherapy 63 mutant p# 63 Preoperative 63 NSCLC tumors 63 thyroid nodule 63 hypothalamus pituitary 63 cTnT 63 percutaneous biopsy 63 TET2 63 creatinine ratio 63 -#.# ± [002] 63 malignant transformation 63 Western blotting 63 prognostic indicators 63 adipogenic 63 catenin 63 survivin 63 resections 63 PITX2 63 transmembrane protein 63 serum TSH 63 antibody titer 63 interferon γ 63 transmural 63 contractile function 63 dyssynchrony 63 transitional cell carcinoma 63 chemoresistant 63 peripheral blood mononuclear 63 upregulates 63 mononuclear 63 radical nephrectomy 63 pmol L 62 gene amplification 62 syngeneic 62 autocrine 62 prostatic tissue 62 EGFR expression 62 nephrogenic 62 #.#ng/ml 62 radiosensitivity 62 Radical prostatectomy 62 hepatoma 62 ERK signaling 62 upregulating 62 VE cadherin 62 D dimer 62 epithelial cell 62 TT genotype 62 IGFBP 62 germline mutations 62 preoperatively 62 myocyte 62 BMP signaling 62 karyotypes 62 coronary stenoses 62 LPS induced 62 tumor perfusion 62 CD# + [002] 62 malignant ovarian 62 CD#c 62 sonographically 62 PCA3 gene 62 osteoblastic 62 serum creatinine levels 62 baseline LDH 62 E cadherin expression 62 Prognostic factors 62 castration resistant 62 invasive lobular 62 occludin 62 androgen suppression 62 aminotransferase ALT 62 tumor resection 62 cerebral ischemia 62 hTERT 62 extraocular 62 astrocytic 62 nmol liter 62 Breslow thickness 62 hypoplasia 62 left ventricular diastolic 62 Histopathologic 62 interobserver agreement 62 plasmacytoid 62 anti apoptotic proteins 62 epithelial ovarian 62 transfected 62 beta1 integrin 62 medically inoperable 62 DNA methylation patterns 62 PC# cells 62 Fig. 2b 62 multivariable adjusted 62 hyperalgesia 62 LRP6 62 striatal 62 transvaginal sonography 62 Figure 1C 62 hyperintense lesions 62 Subgroup analysis 62 fibrin deposition 62 β amyloid 62 Multivariate analysis 62 atherosclerotic lesions 62 acute aortic dissection 62 arteriolar 62 TMPRSS2 ERG fusion 62 hyperplasia 62 Oncotype DX Recurrence Score 62 stratifying patients 62 TP# mutations 62 inotropic 62 clinically localized prostate 62 chemoradiotherapy 62 echocardiographic parameters 62 null mice 62 thyroid carcinomas 62 clusterin 62 endometrioid 62 oncologic outcomes 62 LRP5 62 #p# [001] 62 proapoptotic 62 Akt activation 62 carcinomatosis 62 aspartate aminotransferase 62 glomerular filtration rate 62 estrogen receptor progesterone receptor 62 pretransplant 62 extrahepatic 62 pancreatic carcinoma 62 preoperative chemotherapy 62 LHRH receptor positive 62 #p#.# [002] 62 pneumonectomy 62 lobular 62 raphe 62 neurite outgrowth 62 p#NTR 62 estimated glomerular filtration 62 Endothelial dysfunction 62 serum testosterone 62 BCL2 62 postoperative complication 62 mIU L 62 hENT1 62 prostatic adenocarcinoma 62 HER2 HER2 62 F FLT 62 leukocyte counts 62 CD8 + 62 vestibular schwannomas 62 gastric mucosa 62 biopsied breast 62 regulated kinase ERK 62 preoperative diagnosis 62 ventricular dilatation 62 activating mutations 62 activating mutation 62 amino terminal 62 vascularity 62 melanocyte 62 medullary 62 Dysregulation 62 pancreatic prostate 62 adenomatous polyps 62 gastric cancers 62 urine cytology 62 RIP1 62 xenografts 62 IFN γ 62 beta globin 62 osteoclastic 62 hyperplastic polyps 62 pancreatic lung 62 ventricular myocardium 62 ^ Tc 62 sFlt 1 62 postoperative radiotherapy 62 chromosomal rearrangement 62 unresectable tumors 62 astrocytomas 62 IFN gamma 62 serum cortisol 62 retroperitoneal 62 laterality 62 pAkt 62 VATS lobectomy 62 cardiac troponin 62 EGFR mutations 62 constitutively expressed 62 left ventricular systolic 62 colorectal polyp 62 STAT3 activation 62 antigen PSA levels 62 wedge resection 62 serum homocysteine 62 ABL1 62 CC genotype 62 serum urate levels 62 cholangiocarcinoma 62 cisplatin resistant 62 Bcl xL 62 p tau 62 myocardial ischemia 62 papillary carcinoma 62 SLC#A# [002] 62 rebleeding 62 monocytic 62 endoscopic resection 62 MetS 62 lymph node 62 peritoneal carcinomatosis 62 alkaline phosphatase 62 eNOS 62 ZNF# 62 intraepithelial 62 #F FDG PET 62 3'UTR 62 bronchial epithelial cells 62 nodal dissection 62 serum IgE 62 anterior temporal 62 MMP2 62 IL 1beta 62 C#Y 62 core needle biopsies 62 pleural fluid 62 HIV RNA 62 diabetes mellitus DM 62 pathologic examination 62 FGFR4 62 breast lesions 62 mutated K ras 62 extracranial 62 microvessel 62 left ventricular LV 62 mutated KRAS 62 carotid stenosis 62 miR #a [001] 62 squamous intraepithelial lesions 62 metastatic 62 T1 weighted images 62 renal artery stenosis 62 hypogonadotropic hypogonadism 62 CTNNB1 62 GRP# 62 % Confidence Interval 62 PTEN protein 62 serum IGF 62 tonsillar 62 PDGFR 62 uveal melanoma 62 plasma creatinine 62 hypothalamic pituitary adrenal axis 62 biopsy Gleason 62 squamous cell carcinoma SCC 62 carotid intima media 62 colorectal tumor 62 osteoblast 61 posttransplant 61 EGFR receptor 61 hCG Beta 61 Tie2 61 node metastasis 61 #β estradiol 61 KRAS mutation 61 chromosomal aberrations 61 intronic 61 PCWP 61 mutational status 61 metastatic tumors 61 CaP 61 macroalbuminuria 61 MDA MB 61 calculi 61 procollagen 61 p# mutations 61 TRUS biopsy 61 autonomic dysfunction 61 Computed tomography 61 perioperative mortality 61 neurofibromas 61 MCF7 cells 61 #F FDG 61 activin 61 HCCs 61 lymphopenia 61 morphologic characteristics 61 IgG antibody 61 aminotransferase levels 61 chromosome #q# [001] 61 villous 61 GSTM1 61 seminal vesicles 61 Prostate specific antigen 61 GSTT1 61 CpG island 61 debulking surgery 61 mL/min/#.# m 2 61 apo B 61 ErbB2 positive 61 pretest probability 61 distensibility 61 graft dysfunction 61 #Gy 61 node dissection 61 monocyte 61 uPAR 61 preoperative staging 61 histological subtypes 61 serum calcium levels 61 Multivariate analysis showed 61 N Myc 61 HER2 receptor 61 perfusion abnormalities 61 EpCAM 61 intracoronary 61 Fas ligand 61 cytoreductive surgery 61 aminotransferase 61 adrenocortical cancer 61 central corneal thickness 61 ß amyloid 61 transaminases 61 hepatic lesions 61 E cadherin 61 myocardial viability 61 mU liter 61 hip BMD 61 thyroid stimulating hormone 61 posttreatment 61 TGF beta1 61 hypogonadal 61 CD1d 61 ductal cancer 61 plasminogen activator inhibitor 61 bivariate analysis 61 Recurrence Score 61 fig. S2 61 malignant phenotype 61 epithelial cells lining 61 contralateral breast cancer 61 Adenomas 61 arteriography 61 β1 61 sentinel lymph nodes 61 Upregulation 61 tunica vaginalis 61 EGFR protein 61 neointimal hyperplasia 61 FGFR1 61 neurologic progression 61 liver parenchyma 61 CYP#A# [002] 61 thyrotoxicosis 61 dysplastic 61 immunofluorescence 61 albumin excretion rate 61 liver resection 61 Histologically 61 androgen receptor AR 61 endometrial cancers 61 Activating mutations 61 mitotic 61 ADRB2 61 carotid artery thickness 61 mesothelin 61 osteocalcin 61 serum lactate 61 thyroid stimulating hormone TSH 61 RhoA 61 immunofluorescence staining 61 urothelial cancer 61 basolateral 61 FGFs 61 cytoreduction 61 serum estradiol 61 osteochondromas 61 Foxp3 61 cytological 61 IL #p# 61 genes differentially expressed 61 lesional 61 Microarray analysis 61 HAAH 61 intraepithelial neoplasia 61 retinol binding protein 61 glomerular filtration 61 atypical ductal hyperplasia 61 p# activation 61 intracranial hemorrhage ICH 61 cytotoxicity 61 mitogen activated protein kinase 61 hemodilution 61 caspase activation 61 T2 lesions 61 fulminant hepatic failure 61 endometrial adenocarcinoma 61 RQ PCR 61 ventricular dysfunction 61 neurofilament